Project Investigator Biography
Harold L. Moses, M.D.
Vanderbilt- Ingram Cancer Center
Department of Cancer Biology, Vanderbilt University Medical Center
691 Preston Building,
Nashville, TN 37232-6838
phone: (615) 939-1374
fax: (615) 936-1790
Dr. Harold L. Moses is Director Emeritus of the Vanderbilt-Ingram Cancer Center, the Hortense B. Ingram Professor of Molecular Oncology, the Director of the Frances Williams Preston Laboratories, and Professor of Cancer Biology, Medicine and Pathology at Vanderbilt University School of Medicine. Previously, he was Professor and Chair of the Department of Cell Biology in the School of Medicine at Vanderbilt, and was Founding Director of the Vanderbilt Cancer Center with a concurrent appointment as the B.F. Byrd, Jr. Professor of Clinical Oncology.
Dr. Moses currently chairs the National Cancer Policy Forum of the Institute of Medicine, and co-chairs the Program Steering Committee for the NCIís Tumor Microenvironment Network. He is a member of the Institute of Medicine of the National Academies. Dr. Moses has also served as president of the American Association for Cancer Research, the President of the Association of American Cancer Institutes, Chair of the NIH Chemical Pathology Study Section, Chair of the Molecular Oncogenesis Study Section, a member of the Integration Panel for the US Army Breast Cancer Program, Co-chair of the Breast Cancer Progress Review Group for the National Cancer Institute, and Chair of the NCI Cancer Centers review panel.
Dr. Moses is well known for his work on the transforming growth factor-beta family of growth regulatory peptides. He has devoted much of his career to basic research on growth factors and tumor suppressor genes. While Director of the Vanderbilt-Ingram Comprehensive Cancer Center, Dr. Moses, along with Dr. Samuel Adunyah of Meharry, established the Meharry-Vanderbilt Cancer Partnership. This Partnership has been highly successful in enhancing cancer research at Meharry through funding of projects involving collaborations between Meharry and Vanderbilt faculty and through recruitment of new cancer research faculty to Meharry. The Partnership has also enabled research in racial disparities at both institutions, a major goal of which is determining the basis of disparities in cancer incidence and outcomes in African Americans living in the southeastern United States.
Dr. Moses graduated from Berea College and then obtained an M.D. degree from Vanderbilt University. After residency training in pathology at Vanderbilt and postdoctoral research training at the NIH, he spent five years as a faculty member in pathology at Vanderbilt and twelve years at the Mayo Clinic, the last six of which were as Chair of the Department of Cell Biology.View Partnership Abstract Description
Other Project Investigator
Samuel Evans Adunyah, Ph.D.